Correlation Between Vivos Therapeutics and Amcor Plc

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Amcor Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Amcor Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Amcor plc, you can compare the effects of market volatilities on Vivos Therapeutics and Amcor Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Amcor Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Amcor Plc.

Diversification Opportunities for Vivos Therapeutics and Amcor Plc

-0.71

Correlation Coefficient

Vivos Therapeutics  Amcor Plc

Pay attention - limited upside

The 3 months correlation between Vivos and Amcor is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Amcor plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amcor plc and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Amcor Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amcor plc has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Amcor Plc go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Amcor Plc

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 1.79 times more return on investment than Amcor Plc. However, Vivos Therapeutics is 1.79 times more volatile than Amcor plc. It trades about 0.12 of its potential returns per unit of risk. Amcor plc is currently generating about -0.33 per unit of risk. If you would invest  401.00  in Vivos Therapeutics on October 6, 2024 and sell it today you would earn a total of  36.00  from holding Vivos Therapeutics or generate 8.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.24%
Values	Daily Returns

Vivos Therapeutics  vs.  Amcor plc

Vivos Therapeutics

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Amcor plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amcor plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Vivos Therapeutics and Amcor Plc

The main advantage of trading using opposite Vivos Therapeutics and Amcor Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Amcor Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amcor Plc will offset losses from the drop in Amcor Plc's long position.

The idea behind Vivos Therapeutics and Amcor plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.